Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 1/20 | 0.56 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.56 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.56 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.56 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.55 |
| ▸ | AMY2A | P04746 | 4/20 | 0.54 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CDK1 | P06493 | 1/20 | 0.46 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12595429 | 1.00 | LGALS8 (0.56) | LGALS8LGALS3LGALS4AMY1AENGASE | |
| SCHEMBL12648833 | 1.00 | LGALS8 (0.56) | LGALS8LGALS3LGALS4AMY1AENGASE | |
| SCHEMBL16506646 | 1.00 | LGALS8 (0.56) | LGALS8LGALS3LGALS4AMY1AENGASE | |
| SCHEMBL16510207 | 1.00 | LGALS8 (0.56) | LGALS8LGALS3LGALS4AMY1AENGASE | |
| SCHEMBL12595483 | 1.00 | LGALS8 (0.56) | LGALS8LGALS3LGALS4AMY1AENGASE | |
| SCHEMBL13298857 | 0.95 | CD209 (0.53) | LGALS8LGALS3LGALS4AMY1AENGASE | |
| SCHEMBL13298875 | 0.95 | CD209 (0.53) | LGALS8LGALS3LGALS4AMY1AENGASE | |
| SCHEMBL15255397 | 0.95 | CD209 (0.58) | LGALS8LGALS3LGALS4AMY1AENGASE | |
| SCHEMBL15255404 | 0.95 | CD209 (0.58) | LGALS8LGALS3LGALS4AMY1AENGASE | |
| SCHEMBL15255410 | 0.93 | CD209 (0.60) | LGALS8LGALS3LGALS4AMY1AENGASE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220178937-A1 | QUANTITATIVE DETERMINATION METHOD FOR Hex4, LYSO-GM1, Fuc-GlcNAc-Asn, AND LYSO-SULFATIDE INCLUDED IN CEREBROSPINAL FLUID | JCR PHARMACEUTICALS CO., LTD. (JP) | 2022-06-09 | — | — | US | disclosed |